HearingCompleted
Maintaining America’s Leadership in Biomedical Innovation: FDA’s Role in Advancing U.S. Drug Development.
Jul 15, 20262:15 PM2123, Rayburn House Office Building
Witnesses · 5
1
Dr. Cynthia Verst
President, Design and Delivery Innovation, R&D Solutions, IQVIA
2
Ms. Susan Winckler
CEO, Reagan-Udall Foundation for the FDA
3
Dr. Aaron Kowalski
CEO, Breakthrough T1D
4
Dr. Thomas Hwang
Assistant Professor of Medicine, Brigham and Women's Hospital and Harvard Medical School
5
Mr. Thomas Bollyky
Bloomberg Chair in Global Health, Senior Fellow for International Economics, Law, and Development; and Director of the Global Health Program, Council